Human Health Holdings Limited

SEHK:1419 Stock Report

Market Cap: HK$299.8m

Human Health Holdings Valuation

Is 1419 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 1419 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 1419 (HK$0.79) is trading above our estimate of fair value (HK$0.72)

Significantly Below Fair Value: 1419 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 1419?

Key metric: As 1419 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 1419. This is calculated by dividing 1419's market cap by their current earnings.
What is 1419's PE Ratio?
PE Ratio12.4x
EarningsHK$24.19m
Market CapHK$299.85m

Price to Earnings Ratio vs Peers

How does 1419's PE Ratio compare to its peers?

The above table shows the PE ratio for 1419 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average48.1x
2293 Bamboos Health Care Holdings
8.9xn/aHK$273.7m
9960 Kindstar Globalgene Technology
113.5x88.0%HK$1.1b
6639 Arrail Group
58xn/aHK$1.4b
1846 EuroEyes International Eye Clinic
12.1x26.7%HK$1.3b
1419 Human Health Holdings
12.4xn/aHK$299.8m

Price-To-Earnings vs Peers: 1419 is good value based on its Price-To-Earnings Ratio (12.4x) compared to the peer average (48.1x).


Price to Earnings Ratio vs Industry

How does 1419's PE Ratio compare vs other companies in the HK Healthcare Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
574 Pa Shun International Holdings
2xn/aUS$9.30m
No more companies available in this PE range
1419 12.4xIndustry Avg. 12.4xNo. of Companies9PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 1419 is good value based on its Price-To-Earnings Ratio (12.4x) compared to the Hong Kong Healthcare industry average (12.4x).


Price to Earnings Ratio vs Fair Ratio

What is 1419's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

1419 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio12.4x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 1419's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies